Oragenics, Inc.
OGEN
$1.11
-$0.006-0.54%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.97M | 3.42M | 864.80K | 3.14M | 1.35M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 166.00K | 239.90K | 430.20K | 583.30K | 22.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 208.10K | 177.40K | 386.00K | 248.30K |
| Total Current Assets | 2.14M | 3.87M | 1.47M | 4.11M | 1.62M |
|
|
|||||
| Total Current Assets | 2.14M | 3.87M | 1.47M | 4.11M | 1.62M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 1.09M | 1.09M |
| Total Assets | 2.14M | 3.87M | 1.47M | 5.20M | 2.71M |
|
|
|||||
| Total Accounts Payable | 1.27M | 772.50K | 1.14M | 1.51M | 1.18M |
| Total Accrued Expenses | -- | 404.50K | 211.20K | 93.80K | 202.90K |
| Short-term Debt | 3.00M | 2.55M | 328.50K | 519.40K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.27M | 3.73M | 1.68M | 2.13M | 1.38M |
|
|
|||||
| Total Current Liabilities | 4.27M | 3.73M | 1.68M | 2.13M | 1.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 3.00M | 2.55M | 328.50K | 519.40K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.27M | 3.73M | 1.68M | 2.13M | 1.38M |
|
|
|||||
| Common Stock & APIC | 219.15M | 219.14M | 216.57M | 214.92M | 210.71M |
| Retained Earnings | -221.28M | -219.00M | -216.79M | -213.44M | -210.97M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.13M | 137.70K | -211.90K | 1.48M | -266.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 1.59M | 1.59M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 1.59M | 1.59M |
|
|
|||||
| Total Common Equity | -2.13M | 137.70K | -211.90K | 1.48M | -266.30K |
| Total Preferred Equity | -- | -- | -- | 1.59M | 1.59M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.13M | 137.70K | -211.90K | 3.08M | 1.33M |
|
|
|||||